François Ghiringhelli

58.4k citations
458 papers · 28.1k indexed · 10 hit papers · h-index 78

Impact in

  • Immunology top 0.05%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune cells in cancer
    • T-cell and B-cell Immunology
    • Phagocytosis and Immune Regulation
  • Oncology top 0.05%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Cancer Immunotherapy and Biomarkers 130
    • Colorectal Cancer Treatments and Studies 94
    • Cancer Treatment and Pharmacology 38
    • Immune Cell Function and Interaction 77
    • Immunotherapy and Immune Responses 67
    • Immune cells in cancer 32

François Ghiringhelli

439 papers receiving 27.7k citations

Hit Papers

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth 2012 · 615 citations
615200420262011201850010001.5k2.0k2.5k

Peers

François Ghiringhelli
Comparison fields: 5 of 157
  • Immunology 13.8k
  • Oncology 13.6k
  • Physiology 996
  • Cancer Research 2.5k
  • Biological Psychiatry 371
Replace Oliver Kepp with:
Oliver Kepp France
Michael T. Lotze United States
Lionel Apétoh France
Jeffrey C. Rathmell United States
Klaus Schulze‐Osthoff Germany
Erika L. Pearce United States
Jiahuai Han China
Ira Tabas United States
Florian R. Greten Germany
Dmitry I. Gabrilovich United States
François Ghiringhelli relative to Oliver Kepp France Oliver Kepp's profile →
Citations per field
00.5×1.5×
Oliver Kepp · 1×
Citations per year

Countries citing papers authored by François Ghiringhelli

Since Specialization
Citations

This map shows the geographic impact of François Ghiringhelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Ghiringhelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Ghiringhelli more than expected).

Fields of papers citing papers by François Ghiringhelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Ghiringhelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Ghiringhelli. The network helps show where François Ghiringhelli may publish in the future.

Co-authors

The 25 scholars most cited alongside François Ghiringhelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with François Ghiringhelli Line = papers co-authored together François Ghiringhelli links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20232
3 20231
4 20235
5 20231
6 20232
7 20234
8 20233
9 20230
10 202017
11 201914
12 201969
13 2019111
14 201838
15 201748
16 2016213
17 201516
18 201347
19
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity
Hit paper breakdown →
2010969
20
Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation
Hit paper breakdown →
2005588

About François Ghiringhelli

François Ghiringhelli is a scholar working on Oncology, Immunology, Hepatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 458 papers that have together received 28.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (130 papers), Colorectal Cancer Treatments and Studies (94 papers), Immune Cell Function and Interaction (77 papers), Immunotherapy and Immune Responses (67 papers), Cancer Treatment and Pharmacology (38 papers), Cancer Genomics and Diagnostics (37 papers), Lung Cancer Treatments and Mutations (32 papers) and Immune cells in cancer (32 papers). The work is most often cited by research in Immunology (13.8k citations), Oncology (13.6k citations), Physiology (996 citations), Cancer Research (2.5k citations) and Biological Psychiatry (371 citations). François Ghiringhelli has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Lionel Apétoh, Laurence Zitvogel, Guido Kroemer, Sylvain Ladoire, Cédric Rébé, François Martin, Grégoire Mignot, Antoine Tesnière, Bruno Chauffert and Mélanie Bruchard. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Cancers and OncoImmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026